OBJECTIVE: Numerous studies have implicated the hippocampus and prefrontal cortex in schizophrenia. However, precisely which subregions of the hippocampus and prefrontal cortex are abnormal remain unknown. Our study goal was to investigate the structure of the anterior hippocampus, posterior hippocampus, dorsolateral prefrontal cortex (DLPFC), and orbitofrontal cortex (OFC) simultaneously in thirty-eight patients with schizophrenia and twenty-nine controls to determine which of these subregions are abnormal in schizophrenia. As an exploratory study goal, we investigated the relation of neurocognition to brain structure in schizophrenia patients. METHOD: We generated detailed structural magnetic resonance imaging data and compared hippocampal and prefrontal subregional structural brain volumes between schizophrenia and control groups. We obtained a neurocognitive test battery in schizophrenia patients and studied the association of abnormal brain structures to neurocognition. RESULTS: Structural brain abnormalities were pinpointed to the left anterior hippocampus and left OFC in schizophrenia patients, which were both significantly reduced in volume. The DLPFC and posterior hippocampus, though numerically decreased in volume, were not significantly decreased. Anterior hippocampal volumes were more strongly associated with OFC volumes in schizophrenia patients compared to controls. By contrast, DLPFC volume was unrelated to anterior or posterior hippocampal volume. Both the anterior hippocampus and OFC were independently related to cognitive abnormalities common in schizophrenia, including indices of verbal, language, and executive functions. The DLPFC and posterior hippocampal volumes were unrelated to cognitive measures. CONCLUSIONS: These findings highlight related abnormalities of the anterior hippocampus and OFC in schizophrenia, which may shed light on the pathophysiology of the disorder.
OBJECTIVE: Numerous studies have implicated the hippocampus and prefrontal cortex in schizophrenia. However, precisely which subregions of the hippocampus and prefrontal cortex are abnormal remain unknown. Our study goal was to investigate the structure of the anterior hippocampus, posterior hippocampus, dorsolateral prefrontal cortex (DLPFC), and orbitofrontal cortex (OFC) simultaneously in thirty-eight patients with schizophrenia and twenty-nine controls to determine which of these subregions are abnormal in schizophrenia. As an exploratory study goal, we investigated the relation of neurocognition to brain structure in schizophreniapatients. METHOD: We generated detailed structural magnetic resonance imaging data and compared hippocampal and prefrontal subregional structural brain volumes between schizophrenia and control groups. We obtained a neurocognitive test battery in schizophreniapatients and studied the association of abnormal brain structures to neurocognition. RESULTS:Structural brain abnormalities were pinpointed to the left anterior hippocampus and left OFC in schizophreniapatients, which were both significantly reduced in volume. The DLPFC and posterior hippocampus, though numerically decreased in volume, were not significantly decreased. Anterior hippocampal volumes were more strongly associated with OFC volumes in schizophreniapatients compared to controls. By contrast, DLPFC volume was unrelated to anterior or posterior hippocampal volume. Both the anterior hippocampus and OFC were independently related to cognitive abnormalities common in schizophrenia, including indices of verbal, language, and executive functions. The DLPFC and posterior hippocampal volumes were unrelated to cognitive measures. CONCLUSIONS: These findings highlight related abnormalities of the anterior hippocampus and OFC in schizophrenia, which may shed light on the pathophysiology of the disorder.
Authors: Robert J Thoma; Mollie Monnig; Faith M Hanlon; Gregory A Miller; Helen Petropoulos; Andrew R Mayer; Ron Yeo; Matt Euler; Per Lysne; Sandra N Moses; Jose M Cañive Journal: J Int Neuropsychol Soc Date: 2009-02-10 Impact factor: 2.892
Authors: Daqiang Sun; Lisa Phillips; Dennis Velakoulis; Alison Yung; Patrick D McGorry; Stephen J Wood; Theo G M van Erp; Paul M Thompson; Arthur W Toga; Tyrone D Cannon; Christos Pantelis Journal: Schizophr Res Date: 2009-01-12 Impact factor: 4.939
Authors: Morris B Goldman; Lei Wang; Carly Wachi; Sheeraz Daudi; John Csernansky; Megan Marlow-O'Connor; Sarah Keedy; Ivan Torres Journal: Behav Brain Res Date: 2010-11-17 Impact factor: 3.332
Authors: Stephanie M Perez; David D Aguilar; Jennifer L Neary; Melanie A Carless; Andrea Giuffrida; Daniel J Lodge Journal: Neuropsychopharmacology Date: 2015-06-12 Impact factor: 7.853
Authors: Kathryn M Gill; Daniel J Lodge; James M Cook; Shamim Aras; Anthony A Grace Journal: Neuropsychopharmacology Date: 2011-05-11 Impact factor: 7.853
Authors: Scott A Schobel; Nashid H Chaudhury; Usman A Khan; Beatriz Paniagua; Martin A Styner; Iris Asllani; Benjamin P Inbar; Cheryl M Corcoran; Jeffrey A Lieberman; Holly Moore; Scott A Small Journal: Neuron Date: 2013-04-10 Impact factor: 17.173
Authors: Julia A Scott; Naomi Goodrich-Hunsaker; Kristopher Kalish; Aaron Lee; Michael R Hunsaker; Cynthia M Schumann; Owen T Carmichael; Tony J Simon Journal: J Psychiatry Neurosci Date: 2016-04 Impact factor: 6.186